| | | Glaucoma progression software receives clearance from FDA
July 1, 2009
Software (MatchedFlicker, EyeIC) that monitors the advent and progression of glaucoma through retinal photography has received FDA 510(k) clearance. | | FDA approves implant for macular edema associated with RVO
July 1, 2009
The FDA has approved dexamethasone intravitreal implant 0.7 mg (Ozurdex, Allergan) for the treatment of macular edema following branch retinal vein occlusion or central retinal vein occlusion. | | IOL injector system given 510(k) clearance
July 1, 2009
The FDA has granted 510(k) clearance for an injector system (Epiphany, STAAR Surgical Co.) designed for use with a three-piece new-technology IOL ([NTIOL]; Affinity Collamer, STAAR Surgical) and a silicone NTIOL (Elastimide, STAAR Surgical), according to the devices' manufacturer. | | Besifloxacin approved for use against ocular infections
July 1, 2009
Besifloxacin ophthalmic suspension 0.6% (Besivance, Bausch & Lomb) is a new topical ophthalmic antibacterial indicated for the treatment of bacterial conjunctivitis and administered via sterile ophthalmic drops. | | Committee recommends approval of bepotastine for ocular itching
July 1, 2009
The Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the FDA has recommended the approval of bepotastine besilate ophthalmic solution 1.5% (Bepreve, ISTA Pharmaceuticals Inc.) as an eye-drop treatment for ocular itching associated with allergic conjunctivitis, according to the company. | |
|  More Articles |
| |
| | | Harvard affiliates collaborate on pediatric ophthalmology
July 1, 2009
Two affiliates of Harvard Medical School's Department of Ophthalmology will begin a formal relationship in patient care Aug. 1, creating what the institutions describe as one of the most comprehensive pediatric ophthalmology networks in the country. | | Nidek founder and chairman remembered
July 1, 2009
Hideo Ozawa, founder and chairman of the board of Nidek Co. Ltd., died June 16 at a hospital in Gamagori, Japan. He was 79. | | Dr. Chuck named chairman at Einstein, Montefiore
July 1, 2009
Roy S. Chuck, MD, PhD, has been appointed chairman of ophthalmology and visual sciences at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center. The appointment is effective July 1. | | Gibson appointed director of development for Glaucoma Research Foundation
June 22, 2009
The Glaucoma Research Foundation announced the addition of Candler Gibson as the new director of development. | | PBO warns of the potential danger of fireworks
June 18, 2009
Prevent Blindness Ohio (PBO) urges the public to refrain from purchasing or using backyard fireworks for Fourth of July celebrations. | |
| | More Articles |
|
